Treatment of diseases of the temporomandibular joint (TMJ), complicated by hypertension of the masticatory muscles, remains one of the unsolved problems of dentistry. The purpose of this clinical study is to assess the safety and efficacy of the first Russian botulinum toxin a (BTA) Relatox® for the correction of masticatory muscle hypertension in patients with myofascial pain syndrome, as well as its comparison with the Lantox® by these parameters. Injections of botulinum toxin type A are a method of treatment in patients with myofascial facial pain syndrome with high therapeutic potential. The analysis of clinical results of using the Russian botulinum toxin type A of Relatox® shows high clinical efficacy. Comparative analysis of Lantox® and Relatox® showed no differences in safety and efficacy.
COMPARATIVE PROSPECTIVE STUDY OF THE EFFECTIVENESS AND SAFETY OF RUSSIAN OF THE RUSSIAN BOTULINUM TOXIN-A RELATOX ® IN ORDER TO CORRECT THE OF MASTICATORY MUSCLES HYPERTONE PATIENTS WITH MYOFASCIAL PAIN SYNDROME